Overview
Functional genomics aims to close the gap between genome sequence and biological function by systematically characterizing the roles of genes, their products, and their interactions on a genome-wide scale. While structural genomics provides the static blueprint of an organism’s DNA, functional genomics asks what each element does, when and where it is active, and how it participates in cellular networks. The field integrates data from transcriptomics, proteomics, and high-throughput perturbation screens to assign biological function to every gene. This systems-level perspective has become essential for understanding complex phenotypes.
Methods
Several high-throughput approaches power functional genomics. Loss-of-function screens use RNA interference (RNAi) or CRISPR-Cas9 libraries to knock out genes systematically and observe phenotypic consequences. Gain-of-function screens overexpress cDNA libraries to identify genes that drive particular phenotypes. Protein interaction mapping (via yeast two-hybrid or affinity purification-mass spectrometry) constructs genome-wide interaction networks. Gene expression profiling using RNA-seq or microarrays reveals co-expression patterns that suggest functional relationships. Integration of diverse data types through machine learning predicts gene function with increasing accuracy, assigning annotations such as Gene Ontology terms based on multi-omics evidence.
Applications
Functional genomics drives discovery across all domains of life. In cancer research, CRISPR screens identify genes essential for tumor growth and genes whose loss confers drug resistance. In microbiology, genome-wide fitness assays pinpoint genes required for pathogenesis. Agricultural applications include identifying genes controlling yield, stress tolerance, and nutritional content through combined recombinant DNA technology and functional screening. The field continues to evolve with single-cell technologies and in vivo CRISPR screens that reveal gene function in native tissue contexts, bringing us closer to a complete functional annotation of the genome.
Practical Protocol
For a ChIP-seq experiment to identify transcription factor binding sites, start with crosslinking cells using 1% formaldehyde for 10 minutes at room temperature, then quench with glycine. Chromatin is sheared to 200–600 bp fragments by sonication (e.g., Covaris or Diagenode Bioruptor). Immunoprecipitation uses 2–5 µg of target-specific antibody coupled to Protein A/G magnetic beads overnight at 4°C. After washing, reverse crosslink at 65°C for 6 hours with proteinase K, then purify DNA with column cleanup. Libraries are prepared with end repair, A-tailing, adapter ligation, and 12–15 PCR cycles. Sequence on Illumina with single-end 50 bp reads. Run the ENCODE ATAC-seq pipeline for open chromatin profiling on frozen or fresh cells: nuclei are isolated by lysis buffer incubation, then tagmented with Tn5 transposase at 37°C for 30 min: tagment --input 50000 cells --output tagmented.bam. PCR amplify with barcoded primers for 8–12 cycles and sequence paired-end. For data analysis, align reads with Bowtie2 using --very-sensitive for ATAC-seq or BWA for ChIP-seq. Remove duplicates with Picard MarkDuplicates. Peak calling with MACS2: macs2 callpeak -t aligned.bam -c input.bam -f BAMPE -g hs -n sample -q 0.05. For histone marks like H3K4me3, use broad peak mode with --broad. Quality metrics include the fraction of reads in peaks (FRiP > 1% for transcription factors, >10% for histone marks), NSC (normalized strand coefficient >1.05), and RSC (relative strand correlation >0.8). Differential binding analysis between conditions uses DiffBind in R, and motif enrichment is tested with HOMER or MEME-ChIP.
